ANKRD11 restrains CD8+ T cells in hepatitis B and cancer models
A mouse study found that removing ANKRD11 enhanced CD8+ T-cell activity against chronic hepatitis B virus infection and cancer, but ...
A mouse study found that removing ANKRD11 enhanced CD8+ T-cell activity against chronic hepatitis B virus infection and cancer, but ...
Researchers have identified ANKRD11 as a chromatin regulator whose loss reprograms CD8+ T cells to fight chronic hepatitis B and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine